Difference between revisions of "Plasminogen activator inhibitor-2"
(New page: {{subst:infobox}}) |
|||
Line 1: | Line 1: | ||
− | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
Line 9: | Line 8: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
− | | | + | | Urokinase inhibitor |
|- | |- | ||
| Determination type | | Determination type | ||
− | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
Line 18: | Line 17: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
− | | | + | | Cytosol |
+ | Plasma | ||
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
− | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P05120 P05120 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
− | | | + | | Q83, Q84, Q86 |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
Line 30: | Line 30: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
− | | | + | | SCGFM''QQ''I''Q''KGSYP |
|- | |- | ||
| Structure | | Structure | ||
− | | [http://www.rcsb.org/pdb/explore/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore/explore.do?structureId=1BY7 1BY7] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
Line 42: | Line 42: | ||
|- | |- | ||
| Reference | | Reference | ||
− | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=7910824&dopt=Abstract PMID:7910824] |
|- | |- | ||
| Notes | | Notes | ||
− | | | + | | Polymerization occurs upon transglutaminase action |
+ | |||
+ | Crosslinking by TG2 has no effect on the protein's function/activity. | ||
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | |
Revision as of 04:55, 24 July 2007
Template:Infobox header| Plasminogen activator inhibitor-2 | |
---|---|
Plasminogen activator inhibitor-2 | |
Substrate peptide name | Plasminogen activator inhibitor-2 |
Synonyms | Urokinase inhibitor |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Cytosol
Plasma |
Swissprot ID | P05120 |
Reactive glutamines | Q83, Q84, Q86 |
Reactive lysines | Not determined yet |
Substrate sequence | SCGFMQQIQKGSYP |
Structure | 1BY7 |
Surface accessibility | ASAView pdf |
Disorder prediction | IUPred |
Reference | PMID:7910824 |
Notes | Polymerization occurs upon transglutaminase action
Crosslinking by TG2 has no effect on the protein's function/activity. |
Template:Infobox header | |